Schedule 13D ownership disclosure

Whitehawk Therapeutics, Inc.

Common stock, par value $0.0001 per share · CUSIP: 00032Q104

Event date: 2024-12-19

Filing-level shares
2,263,566
Percent of class
9.2%
  • Neil DesaiReported CIK 0001878692

    Shares: 2,263,566 · Class: 9.2%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000950170-24-139724
Form type
SCHEDULE 13D/A
Filer
Whitehawk Therapeutics, Inc.
CIK
CIK 1422142
Filed
Dec 23, 2024
Reporting period
Dec 19, 2024
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub